obstructive pulmonary pharm Flashcards

(47 cards)

1
Q

long-term control medications to treat asthma

A

PREVENTERS
-anticholinergics
-xanthine derivative
-inhaled corticosteroids
-leukotriene modifiers
-mast cell stabilizers
-long-acting beta agonist (LABA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

quick-relief medications to treat asthma

A

RESCUE/RELIEF
-short-acting beta agonist (SABA)
-albuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

bronchodilators and classes

A

relaxes bronchial smooth muscle + dilates bronchi

3 classes:
1. beta-adrenergic agonist
2. anti-cholinergics
3. xanthine derivatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

beta-adrenergic agonists meds

A

long or short acting
short: albuterol + levabuterol –> rescue (4-6hr)
long: salmeterol + formeterol –> preventer (12-24hr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

beta-adrenergic agonists: MOA

A

mimic SNS - fight or flight
relax/dilate airway by stimulating beta2 adrenergic receptors throughout lungs

*goal: bronchial dilation and increased airflow in and out of lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 subtypes of beta adrenergic agonists

A
  1. non-selective adrenergic
  2. non-selective beta-adrenergic: stimulate beta1 and beta2 (metaproterenol)
  3. selective beta2 receptors: (albuterol) preferred for pulmonary conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

non-selective beta-adrenergic agonist

A

epinephrine
*stimulate beta 1 (CV effects- increased HR, BP), beta 2, alpha receptors (vasoconstriction)
*decreases edema/swelling in mucous membranes, limits amt of secretions
*CNS stimulation –> nervousness, tremors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

beta-adrenergic agonist: indications/contraindications

A

prevention or relief of asthma, bronchitis, other pulmonary conditions

*contraindications: uncontrolled HTN, cardiac dysrhythmias, high risk for stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

beta-adrenergic agonist: nursing considerations

A

effects may be diminished with beta blockers

avoid use with MAOI’s and sympathomimetics (ephedrine, Sudafed) –> HTN

raises BS –> diabetics may need higher doses of meds (insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

beta-adrenergic agonist: side effects

A

non-selective have the most
beta2: HTN or hypotension
short half life
can reverse effects with beta blockers ***WATCH for bronchospasm

**insomnia, restlessness, anorexia, cardiac stimulation, hyperglycemia, tremor, vascular headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MDI

A

metered dose inhaler - non breath activated
(+): portable, convenient

(-): pt coordination essential, high pharyngeal deposition, difficult to deliver high doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DPI

A

dry powder inhaler - breath activated
(+): propellant not required, convenient, portable

(-): diff to deliver high doses, high pharyngeal deposition, cannot use with endotracheal or tracheotomy tubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

nebulizer

A

(+): pt coordination not required, high doses possible
(-): expensive, possible contamination, device prep required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

selective beta-agonist: albuterol

A

RESCUE!! ASTHMA ATTACKS!!! acute episodes of wheezing, SOA, chest tightness
mostly asthma - also bronchitis, emphysema

SABA - onset in minutes
inhalation: q 4-6hr

delivery method: MDI or nebulizer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

albuterol: teaching points

A

regularly scheduled daily use is NOT recommended
*use of more than 1 canister (200 actuations) per month indicates inadequate control of asthma and need for initiating or intensifying anti-inflammatory therapy

*take 15 min before exercise for exercise-induced asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

salmeterol

A

LABA - MAINTENANCE/PREVENTION
2x/day - DPI

indications: worsening COPD, mod-severe asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

salmeterol: teaching points

A

associated with increased asthma-related deaths (common in African Americans)

always given with an inhaled corticosteroid - not intended for use by itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

anticholinergics

A

bronchodilator - work on acetylcholine receptors
turns off cholinergic (PNS) and turns on SNS –> bronchodilation –> increases perfusion to heart, lungs, brain

*by blocking acetylcholine, we inhibit normal physiological response (mucous production and bronchoconstriction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

anticholinergic: ipratropium

A

blocks action of acetylcholine - creates bronchodilation

used for prophylaxis and maintenance

often given in combo with albuterol

20
Q

side effects of anticholinergics

A

dry as a bone, hot as a hare, blind as a bat, red as a beet, mad as a hatter

dry throat, dry mouth, dry eyes, constipation, hot, decreased sweating, blurred vision, tachycardia, sedation, dizziness, confusion, hallucinations

21
Q

theophylline and aminophylline: class and MOA

A

bronchodilators - xanthine derivatives
MOA: increases levels of the cAMP enzyme by inhibiting phosphodiesterase - stimulates CNS and CVD system

22
Q

theophylline and aminophylline: indication

A

preventive for asthma and COPD exacerbation

23
Q

theophylline and aminophylline: contraindications

A

uncontrolled cardiac dysrhythmias, seizure disorders, hyperthyroid, peptic ulcers

interactions: caffeine (increase SE’s), smoking (decrease absorption)

24
Q

theophylline and aminophylline: side effects

A

toxicity - N/V/D, insomnia, headache, tachycardia, dysrhythmias, seizures (elders)

25
xanthine derivatives: theophylline and aminophylline: nursing considerations
second-line bc high risk of toxicity/drug interactions *macrolide ATB, allopurinol, cimetidine, quinolones, flu vaccine, oral contraceptives narrow therapeutic index - monitor serum levels
26
anti-inflammatories
LTRA's, inhaled corticosteroids, mast cell stabalizers
27
leukotriene receptor antagonist
montelukast zafirlukast
28
montelukast zafirlukast MOA
prevent leukotrienes from attaching to receptors located on immune cells and within lungs --> prevents inflammation *leukotrienes cause: inflammation, bronchoconstriction, mucus production
29
montelukast zafirlukast nursing considerations
montelukast: > 12 months old zafirlukast: > 5 years old
30
montelukast zafirlukast indications
oral prophylaxis and chronic treatment of asthma in adults and children + allergies route: PO (chewable or granules)
31
montelukast zafirlukast side effects
headache, nausea, dizziness, insomnia, diarrhea montelukast: few drug interactions zarfirlukast: several drug interactions
32
inhaled corticosteroid
beclomethasone diproprionate budesonide fluticasone
33
inhaled corticosteroids: MOA
reduce inflammation and enhance activity of beta agonists help with bronchodilation
34
inhaled corticosteroids: indications/considerations
may take several weeks to see effect route: nebulizer or MDI for prevention of persistent asthma attacks + long-term maintenance of severe COPD
35
inhaled corticosteroids: side effects
pharyngeal irritation, dry mouth, coughing, oral fungal infections **RINSE MOUTH AFTER USE
36
teaching point for asthma w/ inhaled corticosteroids
take on a regular schedule, not as needed! give bronchodilator first --> will allow more absorption of steroid
37
inhaled glucocorticoids and bronchodilators are used in combination for
moderate to severe asthma long half lives + onset in minutes *budesonide+formeterol *fluticasone+salmeterol
38
mast cell stabilzer
cromolyn
39
cromolyn: MOA
stabilize membranes of mast cells and precent release of broncho-constrictive inflammatory substances
40
cromolyn: indication
prevention of acute asthma attacks *take 15-20 min prior to known triggers
41
monoclonal antibody anti-asthmatic
omalizumab *newest generation
42
omalizumab: MOA
monoclonal antibody which selectively binds to immunoglobulin IgE, which limits release of mediators of allergic response (decreases hyper responsiveness)
43
omalizumab: indications/considerations
add on therapy for asthma route: injection *monitor closely for hypersensitivity rxn --> anaphylaxis big risk
44
selective PDE-4 inhibitor
roflumilast
45
roflumilast: MOA
selectively inhibits PDE4 enzyme in the lung cells --> decreases inflammation in lungs
46
roflumilast: indications
prevention of COPD exacerbations route: oral
47
roflumilast: side effects
N/V/D, headaches, muscle spasms, decreased appetite, uncontrollable tremors